University of California San Francisco
Give to UCSFA workplace ban on the sale of sugar-sweetened beverages led to a 48.5 percent average reduction in their consumption and significantly less belly fat among 202 participants in a study by researchers at UCSF.
The cause of the pancreatic inflammation plaguing a rural California family has been a medical mystery since it was first described 51 years ago. Now genetic sleuth-work by researchers from UC San Francisco and the University of Chicago has solved the mystery: pointing to a novel gene mutation as the cause of the family’s inherited pancreatitis.
Study finds that young adults in the United States who are food insecure are slightly more likely to be obese, and are significantly more likely to suffer from disorders associated with high BMI, as well as obstructive airway diseases like asthma.
For the 21st year, UCSF Health has been listed among the top 10 hospitals nationwide in the prestigious U.S. News & World Report’s Best Hospitals survey.
Examination of human tissue samples suggested that T2D may represent a reversion to a more infant-like metabolic state.
UCSF Benioff Children’s Hospitals rank among the nation’s best in all 10 specialties assessed in the 2019-20 U.S. News & World Report annual survey of Best Children’s Hospitals.
A two-week course of an experimental immunotherapy called teplizumab dramatically reduced type 1 diabetes (T1D) diagnosis rates in people at high risk for the disease, according to newly published
Ten finalists competed in the fifth annual Grad Slam to inform and entertain with three-minute talks based on their own research.
Tobacco conglomerates that used colors, flavors and marketing techniques to entice children as future smokers transferred these same strategies to sweetened beverages when they bought food and drinks companies.
A UCSF study of human and mouse pancreatic tissue suggests a new origin story for type 1 diabetes.
UCSF researchers have for the first time transformed human stem cells into mature insulin-producing cells, a major breakthrough in the effort to develop a cure for type 1 (T1) diabetes.